AZNCF News and Press, AstraZeneca Plc From 02/03/20

Quick Take Revolution Medicines ( RVMD ) intends to raise $150 million from the sale of its common stock, according to an amended registration statement. The company is in Phase 1/2 trials for the development of treatments for various types of cancers. RVMD has produced promising early r...

Quick Take Beam Therapeutics ( BEAM ) intends to raise $100 million from the sale of its common stock, per an amended registration statement . The company is advancing a pre-clinical set of programs for the treatment of various diseases that may possibly be treated via gene editing of a s...

Quick Take Arcutis Biotherapeutics ( ARQT ) intends to raise $125 million from the sale of its common stock in an IPO, per an amended registration statement . The company is advancing a pipeline of treatment candidates for various skin conditions. For its lead candidate, ARQT plans to h...

Amarin Corporation PLC ( AMRN ) is currently on a roll as the company is gearing up for the expanded market launch of its potential blockbuster drug Vascepa, which is now the only drug approved in the United States for lowering the risk of cardiovascular events in conjunction with statin the...

The 180-day lockup period for Castle Biosciences Inc . ( CSTL ) ends on January 21, 2020 . When the lockup ends, company's pre-IPO shareholders and insiders may choose to sell more than 10.4 million shares of CSTL in the secondary market. The number of currently-restricted shares dwarfs the ...

Introduction In this edition of the Focus on Europe series, we are having a closer look at a small-cap (110M EUR market cap) in Belgium that doesn’t even have an OTC or pink sheets listing. Its IPO in 2017 was hyped, but the share price has lost approximately 80% since then as all h...